| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 460 | 1.640 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2020 | 127 | 1.340 |
Why?
|
| Heart Defects, Congenital | 15 | 2024 | 1887 | 1.190 |
Why?
|
| Heart Valve Prosthesis | 3 | 2023 | 314 | 1.060 |
Why?
|
| Pulmonary Valve | 2 | 2019 | 96 | 1.050 |
Why?
|
| Angioplasty, Balloon | 3 | 2017 | 162 | 1.040 |
Why?
|
| Cardiac Catheterization | 8 | 2023 | 669 | 0.920 |
Why?
|
| Treatment Outcome | 22 | 2024 | 13093 | 0.790 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.790 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 5 | 0.790 |
Why?
|
| Stents | 6 | 2020 | 880 | 0.750 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 466 | 0.730 |
Why?
|
| Septal Occluder Device | 2 | 2019 | 45 | 0.690 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 1099 | 0.680 |
Why?
|
| Aortic Valve | 3 | 2019 | 467 | 0.650 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 221 | 0.620 |
Why?
|
| Dyspnea | 1 | 2020 | 160 | 0.610 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2019 | 6 | 0.610 |
Why?
|
| Aortic Coarctation | 2 | 2017 | 108 | 0.610 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 60 | 0.610 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 19 | 0.600 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2016 | 19 | 0.590 |
Why?
|
| Hypoxia | 1 | 2020 | 267 | 0.580 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 153 | 0.580 |
Why?
|
| Heart Diseases | 2 | 2013 | 519 | 0.550 |
Why?
|
| Aortic Diseases | 1 | 2020 | 202 | 0.550 |
Why?
|
| Transposition of Great Vessels | 2 | 2017 | 136 | 0.540 |
Why?
|
| Hypertension, Pulmonary | 4 | 2017 | 474 | 0.530 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 1163 | 0.530 |
Why?
|
| Norwood Procedures | 1 | 2017 | 105 | 0.500 |
Why?
|
| Bioprosthesis | 1 | 2017 | 117 | 0.500 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 212 | 0.480 |
Why?
|
| Heart Failure | 5 | 2022 | 2428 | 0.480 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 61 | 0.470 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 358 | 0.470 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 147 | 0.460 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2015 | 29 | 0.460 |
Why?
|
| Arterial Switch Operation | 1 | 2015 | 26 | 0.460 |
Why?
|
| Cardiology Service, Hospital | 1 | 2014 | 15 | 0.440 |
Why?
|
| Behcet Syndrome | 1 | 2014 | 17 | 0.430 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 33 | 0.430 |
Why?
|
| Hospitals, Pediatric | 3 | 2018 | 795 | 0.430 |
Why?
|
| Hemodynamics | 4 | 2020 | 858 | 0.420 |
Why?
|
| Health Resources | 1 | 2014 | 127 | 0.400 |
Why?
|
| Aneurysm, False | 1 | 2014 | 97 | 0.390 |
Why?
|
| Adult | 22 | 2024 | 31608 | 0.350 |
Why?
|
| Humans | 40 | 2024 | 133147 | 0.350 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 105 | 0.320 |
Why?
|
| Women's Health | 1 | 2011 | 150 | 0.310 |
Why?
|
| Prosthesis Design | 4 | 2019 | 663 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 258 | 0.280 |
Why?
|
| Female | 24 | 2024 | 71382 | 0.250 |
Why?
|
| Fontan Procedure | 3 | 2019 | 191 | 0.230 |
Why?
|
| Retrospective Studies | 13 | 2024 | 17520 | 0.220 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2024 | 227 | 0.220 |
Why?
|
| Young Adult | 10 | 2018 | 9917 | 0.200 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 63 | 0.190 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 546 | 0.190 |
Why?
|
| Child | 8 | 2022 | 25828 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 649 | 0.180 |
Why?
|
| Hospital Mortality | 4 | 2017 | 1095 | 0.180 |
Why?
|
| Adolescent | 12 | 2019 | 20528 | 0.170 |
Why?
|
| Hope | 1 | 2020 | 14 | 0.160 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2017 | 22 | 0.160 |
Why?
|
| Solutions | 1 | 2019 | 67 | 0.150 |
Why?
|
| Off-Label Use | 1 | 2019 | 28 | 0.150 |
Why?
|
| Anticoagulants | 3 | 2022 | 629 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 174 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 120 | 0.140 |
Why?
|
| Male | 17 | 2024 | 65472 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2024 | 699 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 121 | 0.140 |
Why?
|
| Time Factors | 6 | 2024 | 6541 | 0.140 |
Why?
|
| Syndrome | 1 | 2020 | 1173 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 93 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 214 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 132 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 201 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 207 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 36 | 0.130 |
Why?
|
| Ductus Arteriosus | 1 | 2017 | 61 | 0.130 |
Why?
|
| Vena Cava, Superior | 1 | 2016 | 59 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 34 | 0.120 |
Why?
|
| Femoral Artery | 1 | 2016 | 192 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2022 | 887 | 0.120 |
Why?
|
| Middle Aged | 9 | 2023 | 28911 | 0.120 |
Why?
|
| Executive Function | 1 | 2016 | 124 | 0.120 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 334 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 152 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2019 | 376 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2015 | 99 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2017 | 3169 | 0.110 |
Why?
|
| Thoracotomy | 1 | 2015 | 112 | 0.110 |
Why?
|
| Pulmonary Circulation | 1 | 2015 | 122 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 179 | 0.110 |
Why?
|
| Survivors | 1 | 2016 | 358 | 0.110 |
Why?
|
| Aorta | 1 | 2017 | 557 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1200 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 376 | 0.100 |
Why?
|
| Electric Countershock | 1 | 2014 | 74 | 0.100 |
Why?
|
| Risk Factors | 6 | 2018 | 10930 | 0.100 |
Why?
|
| Stroke | 1 | 2022 | 1079 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 544 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2015 | 3715 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2015 | 998 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2015 | 167 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 158 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2017 | 540 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 270 | 0.100 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 303 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 475 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 321 | 0.100 |
Why?
|
| Survival Rate | 2 | 2018 | 2204 | 0.090 |
Why?
|
| Echocardiography | 1 | 2018 | 1127 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 2286 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 294 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1307 | 0.090 |
Why?
|
| Cognition | 1 | 2016 | 815 | 0.090 |
Why?
|
| Infant | 4 | 2019 | 13235 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2014 | 415 | 0.080 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 134 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2014 | 572 | 0.080 |
Why?
|
| Age Factors | 2 | 2014 | 2954 | 0.080 |
Why?
|
| Patient Admission | 1 | 2011 | 190 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 3087 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 552 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5434 | 0.080 |
Why?
|
| Disease Management | 1 | 2013 | 565 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 509 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1837 | 0.070 |
Why?
|
| Texas | 2 | 2014 | 3664 | 0.070 |
Why?
|
| Incidence | 2 | 2018 | 3385 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2022 | 718 | 0.070 |
Why?
|
| United States | 5 | 2018 | 11711 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 679 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 1166 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3360 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2241 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1418 | 0.050 |
Why?
|
| Amiodarone | 1 | 2024 | 46 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1910 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1340 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8627 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 62 | 0.050 |
Why?
|
| Pregnancy | 2 | 2014 | 7586 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 14862 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 5030 | 0.040 |
Why?
|
| Aged | 3 | 2014 | 21446 | 0.040 |
Why?
|
| Heart Rate | 1 | 2024 | 586 | 0.040 |
Why?
|
| Prevalence | 3 | 2012 | 2628 | 0.040 |
Why?
|
| Warfarin | 1 | 2022 | 134 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1463 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 519 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 131 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 142 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 43 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 209 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 1620 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 113 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 88 | 0.030 |
Why?
|
| Length of Stay | 2 | 2012 | 1392 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 169 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 373 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 36189 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 182 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1182 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 202 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 463 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1118 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 988 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 1582 | 0.020 |
Why?
|
| Phenylpropionates | 1 | 2011 | 3 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 856 | 0.020 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2011 | 15 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2011 | 37 | 0.020 |
Why?
|
| Epoprostenol | 1 | 2011 | 70 | 0.020 |
Why?
|
| Pyridazines | 1 | 2011 | 54 | 0.020 |
Why?
|
| Heart Atria | 1 | 2014 | 334 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2016 | 789 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 719 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 563 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2717 | 0.020 |
Why?
|
| Transition to Adult Care | 1 | 2011 | 115 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 288 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1253 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3406 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 410 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 997 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2011 | 231 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3734 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2854 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5188 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1730 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 6570 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 936 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3863 | 0.010 |
Why?
|